Incorrect bcoz it would come under an 'exceptions to rule 3.1' to continuous disclosure ...??
Cardiex Feb 1 announcement, discloses its position in in relation to Tranche1, Tranche2 and Tranche 3,
So why would they not continue their full disclosure . It would be inconsistent not to continue full disclosure.
I maintain if they haven't disclosed any change then it hasn't happened.
happy to be proven wrong
Incorrect bcoz it would come under an 'exceptions to rule 3.1'...
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
